Nucor Corp. (NYSE: NUE) was maintained as Overweight but the target price was lowered to $66 from $70 (versus a $53.68 close) at KeyBanc Capital Markets. The 52-week range is $49.79 to $68.84, and the consensus target price is $68.54.
Pure Storage Inc. (NYSE: PSTG) was maintained as Hold but the price target was cut to $20 from $22 (versus a $20.60 close) at Stifel. The shares were indicated to open down by about 18% at $16.85 after its earnings. The 52-week range is $13.99 to $29.14. The consensus target price is $25.56.
Redfin Corp. (NASDAQ: RDFN) was raised to Neutral from Underperform at D.A. Davidson. The 52-week range is $13.50 to $26.01. The consensus target price is $21.38.
Ryanair Holdings PLC (NASDAQ: RYAAY) was downgraded to Reduce from Neutral at HSBC. After its American depositary shares closed up 3.6% at $70.19, the stock was indicated down 3.1% at $68.00 on Wednesday. The 52-week range is $65.61 to $121.45. The consensus target price is $82.50.
Semtech Corp. (NASDAQ: SMTC) was started with an Outperform rating and assigned a $56 price target (versus a $44.76 close) at Cowen. The 52-week range is $41.28 to $60.55. The consensus target price is $58.18.
Tesla Inc. (NASDAQ: TSLA) was reiterated as Sell and the target price was lowered to $191 from $238 at Citigroup. The 52-week range is $195.25 to $387.46. The consensus target price is $283.32.
Titan Medical Inc. (NASDAQ: TMDI) was started with an Overweight rating and assigned a target price of $6 at Piper Jaffray. Shares closed up 6.9% at $2.71 ahead of the call, in a 52-week range of $1.05 to $198.00. But this still represents more than 100% upside, even with a 4.4% rise to $2.83 early on Friday. This company had only an $86 million market cap as of Tuesday’s closing bell.
Vishay Intertechnology Inc. (NYSE: VSH) was started as Market Perform at Cowen. The 52-week range is $15.91 to $26.50. The consensus target price is $18.50.
Zayo Group Holdings Inc. (NASDAQ: ZAYO) was downgraded to Market Perform from Outperform at Raymond James. The 52-week range is $20.27 to $39.66, and the consensus target price is $34.85.
Jefferies has four winners it sees from 5G, and the firm was lucky enough not to have Qualcomm on there considering a judge’s ruling brings up antitrust concerns for the leader in mobility chipsets.
Tuesday’s top analyst calls included Tesla, Uber, Amgen, Biogen, Gilead Sciences, Deckers Outdoor, Vertex Pharmaceuticals, KKR and many more.